Correction to: Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Works matching IS 01145916 AND DT 2019 AND VI 42 AND IP 11
Results: 9
1
2
Benefit-Risk Assessment of Alogliptin for the Treatment of Type 2 Diabetes Mellitus.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
Non-Vitamin K Antagonist Oral Anticoagulants and Angioedema: A Cohort and Case-Crossover Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Prevalence of Medication Errors Among Paediatric Inpatients: Systematic Review and Meta-Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Transparent Reporting on Research Using Unstructured Electronic Health Record Data to Generate 'Real World' Evidence of Comparative Effectiveness and Safety.
- Published in:
- 2019
- By:
- Publication type:
- journal article
8
Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem.
- Published in:
- 2019
- By:
- Publication type:
- journal article
9
Identifying the DEAD: Development and Validation of a Patient-Level Model to Predict Death Status in Population-Level Claims Data.
- Published in:
- 2019
- By:
- Publication type:
- journal article